Thyroid autoimmunity and hypothyroidism are associated with deep molecular response in patients with chronic myeloid leukemia on tyrosine kinase inhibitors.

Autor: Rodia, R., Pani, F., Caocci, G., La Nasa, G., Simula, M. P., Mulas, O., Velluzzi, F., Loviselli, A., Mariotti, S., Boi, F.
Zdroj: Journal of Endocrinological Investigation; Feb2022, Vol. 45 Issue 2, p291-300, 10p
Databáze: Complementary Index
Externí odkaz: